Jocelyn Moyes to Respiratory Syncytial Virus Infections
This is a "connection" page, showing publications Jocelyn Moyes has written about Respiratory Syncytial Virus Infections.
Connection Strength
6,772
-
Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 - 2018. BMC Infect Dis. 2024 Oct 09; 24(1):1128.
Score: 0,760
-
The attributable fraction of respiratory syncytial virus among patients of different ages with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016. Int J Infect Dis. 2023 Sep; 134:71-77.
Score: 0,690
-
The economic burden of RSV-associated illness in children aged?
View in: PubMed
Score: 0,685
The burden of RSV-associated illness in children aged?
View in: PubMed
Score: 0,685
Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting. J Infect. 2017 10; 75(4):346-355.
Score: 0,459
Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S217-26.
Score: 0,359
Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
Score: 0,192
The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya. BMC Public Health. 2024 09 04; 24(1):2410.
Score: 0,189
Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study. J Infect. 2024 May; 88(5):106154.
Score: 0,183
Incidence and transmission of respiratory syncytial virus in urban and rural South Africa, 2017-2018. Nat Commun. 2024 01 02; 15(1):116.
Score: 0,180
Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis. Lancet Infect Dis. 2024 Apr; 24(4):361-374.
Score: 0,180
Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa. Influenza Other Respir Viruses. 2023 Dec; 17(12):e13229.
Score: 0,179
Transient increased risk of influenza infection following RSV infection in South Africa: findings from the PHIRST study, South Africa, 2016-2018. BMC Med. 2023 11 15; 21(1):441.
Score: 0,178
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. BMC Med. 2023 03 31; 21(1):120.
Score: 0,171
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022 05 28; 399(10340):2047-2064.
Score: 0,161
Cohort profile: A Prospective Household cohort study of Influenza, Respiratory syncytial virus and other respiratory pathogens community burden and Transmission dynamics in South Africa, 2016-2018. Influenza Other Respir Viruses. 2021 11; 15(6):789-803.
Score: 0,152
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries. Influenza Other Respir Viruses. 2021 11; 15(6):732-741.
Score: 0,152
Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021 07; 26(29).
Score: 0,151
Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance. Influenza Other Respir Viruses. 2020 11; 14(6):638-646.
Score: 0,138
The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus-associated Severe Respiratory Illness in South African Infants, 2011-2016. Clin Infect Dis. 2019 11 27; 69(12):2208-2211.
Score: 0,136
Approaches to use the WHO respiratory syncytial virus surveillance platform to estimate disease burden. Influenza Other Respir Viruses. 2020 11; 14(6):615-621.
Score: 0,134
Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014. J Pediatric Infect Dis Soc. 2019 Sep 25; 8(4):325-333.
Score: 0,134
The Role of Human Immunodeficiency Virus in Influenza- and Respiratory Syncytial Virus-associated Hospitalizations in South African Children, 2011-2016. Clin Infect Dis. 2019 02 15; 68(5):773-780.
Score: 0,128
Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. Lancet Glob Health. 2017 10; 5(10):e984-e991.
Score: 0,117
Deaths associated with respiratory syncytial and influenza viruses among persons =5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). Emerg Infect Dis. 2015 Apr; 21(4):600-8.
Score: 0,098
Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S227-37.
Score: 0,090
Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S246-54.
Score: 0,090